Skip to content

Neural Mechanisms of Imaginal and in Vivo Exposure

Neural Mechanisms of Imaginal and in Vivo Exposure: Exploring the Differences Between Imaginal and in Vivo Exposure, Using fMRI and Psychophysiology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05193383
Enrollment
87
Registered
2022-01-14
Start date
2022-04-07
Completion date
2023-03-01
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear of Spiders

Keywords

Imaginal exposure, Exposure, Mental Imagery

Brief summary

Imaginal exposure is a widely used and effective psychological treatment technique. Recent research suggests that neural activations and emotional responses during imaginal exposure are similar to those elicited during in vivo exposure. However, to the investigators knowledge, no direct comparison between in vivo and imaginal exposure has been performed during neuroimaging. This study compares neural activations and emotional responses during imaginal and in vivo exposure. This study also explores the generalizability of fear reduction achieved through imaginal exposure to fear responses elicited by in vivo stimuli, and vice versa, in a follow-up session approximately one week later. A better understanding of the mechanisms behind both types of exposure could have significant clinical utility, as well as elucidate the differences between fear created from outward stimuli and fear created from inward stimuli, such as mental imagery.

Detailed description

The study includes participants fearful of spiders and entails two experimental sessions, roughly one week apart. The first session includes brain imaging using functional magnetic resonance imaging (fMRI). During the first session, participants will be randomized into one of two conditions - in vivo exposure or imaginal exposure. In the in vivo exposure condition, participants will be shown video clips of spiders (fearful stimuli) and leaves (neutral stimuli) in different situations. In the imaginal exposure condition, participants will be instructed to produce mental imagery of the corresponding stimuli used for in vivo exposure. Previous research found that the brief exposure procedure used during session 1 produced a fear reduction when the procedure was repeated one week later. Thus, in order to conceptually replicate this finding, and to examine the generalizability of fear reduction, participants return roughly one week later for a follow-up session. In the follow-up session, participants undergo a similar exposure procedure as used in session 1, but with half of the stimuli in vivo and the other half of the stimuli as mental imagery. In this way, it can be studied whether fear reduction generalize from exposure modality to another. The effects of imaginal and in vivo exposure on avoidance behavior towards fear-provoking stimuli (spiders) will also be assessed using an approach-avoidance conflict paradigm, using pictures of spiders to probe spider fear. The current study will also explore the impact of mental imagery vividness during imaginal exposure on fear reduction. Additionally, the study will assess if vividness level can predict the generalizability of the effects of imaginal exposure to fear-provoking stimuli (mental imagery of a spider) on subsequent fear responses to to in vivo stimuli (film clip of a spider) one week later. Functional magnetic resonance imaging (7T) is used to measure neural activations (session 1). Skin conductance is used to measure arousal response (session 1 & 2). Subjective fear and mental imagery vividness ratings will also be collected.

Interventions

Session 1 (Day 1): Participants receive repeated exposure to mental imagery of fear-provoking stimuli (spiders) and neutral stimuli (leaves) while undergoing brain imaging med fMRI.

BEHAVIORALExposure

Session 2 (Ca one week): Participants receive both imaginal and in vivo exposure to fear-provoking stimuli and neutral stimuli (both arms are exposed to both video clips (in vivo exposure) and mental imagery (imaginal exposure). Session 2 is conducted in the laboratory, i.e., no brain imaging.

BEHAVIORALApproach-avoidance conflict

Session 2 (Ca one week): Spider fear is probed by an approach-avoidance conflict task. Participants can receive varying small rewards for watching pictures of spiders, or avoid the spider pictures at the cost of not receiving a reward (neutral pictures are shown instead).

Session 1 (Day 1): in vivo exposure. Participants receive repeated exposure to film clips of fear-provoking stimuli (spiders) and neutral stimuli (leaves) while undergoing brain imaging med fMRI.

Sponsors

Uppsala University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Willing and able to provide informed consent and complete study procedures * Fear of spiders

Exclusion criteria

* Current psychiatric disorder other than spider phobia * Current use of psychotropic medication * Current neurological conditions * MRI-contraindications (i.e metal implants in skull)

Design outcomes

Primary

MeasureTime frameDescription
Blood oxygen level dependent contrast (BOLD-signal) during exposure to fearful stimuli (in vivo or imaginal).Day 1BOLD-signal is assessed using functional magnetic resonance imaging.
Physiological arousal response during exposure (in vivo or imaginal).Day 1Skin-conductance responses are used as a measure of physiological arousal response, i.e. event-related rise in electrodermal activity as a response to stimulus. Unit of measure is microSiemens.
Physiological arousal response during follow-up exposureOne week after Day 1Skin-conductance responses are used as a measure of physiological arousal response, i.e. event-related rise in electrodermal activity as a response to stimulus. Unit of measure is microSiemens.
Ratings of subjective fear experienced during exposure to fearful stimuli and neutral stimuliDay1Scale 0-100; no fear at all - extreme fear

Secondary

MeasureTime frameDescription
Vividness of visual imagery Questionnaire (VVIQ)One week after Day 1VVIQ is used to measure individual differences in Vividness of Visual mental Imagery; scale: 16-80 where higher scores represent a higher ability for visual imagery.
Ratings of subjective fear participants expect to experience during exposure to fearful stimuliDay 1 & one week after Day 1Scale 0-100; no fear at all - extreme fear
Amount of watching film clips (not applicable during imaginal exposure).Day 1 & one week after Day 1Assessment of avoidance when watching film clips. To what extent did you watch the film clips (i.e. not close your eyes)? Scale 0-100% of film clips.
Number of approach-avoidance decisions during an approach-avoidance behaviour task using fearful stimuli (spiders)One week after Day 1Number of participants' decisions to avoid looking at a fearful stimuli, or to look at them and be compensated with at small amount.
Task-specific mental imagery vividness ratings to fearful and neutral stimuli during imaginal exposure, and follow-up exposure (not applicable during in vivo exposure).Day 1 & one week after Day 1Vividness of Imagery (scale: 1-5; no image at all - image as clear and vivid as real life)
Spielberger State-Trait Anxiety Inventory (STAI-T)One week after Day 1STAI-T is a self-rated questionnaire which assess trait anxiety. Scale: 20-80 in the participants where higher scores represent higher levels of trait anxiety

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026